Technical Analysis for BAX - Baxter International Inc.

Grade Last Price % Change Price Change
grade F 82.89 2.68% 2.16
BAX closed up 0.45 percent on Friday, August 7, 2020, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical BAX trend table...

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish 2.68%
Calm After Storm Range Contraction 2.68%
NR7 Range Contraction 2.68%
NR7-2 Range Contraction 2.68%
Lower Bollinger Band Walk Weakness 2.68%
Multiple of Ten Bullish Other 2.68%
Oversold Stochastic Weakness 2.68%
Calm After Storm Range Contraction 3.14%
NR7 Range Contraction 3.14%
Lower Bollinger Band Walk Weakness 3.14%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates in two segments, BioScience and Medical Products. The BioScience segment processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; biosurgery products; and certain vaccines. The Medical Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, and inhalation anesthetics. It also provides products and services related to pharmacy compounding, drug formulation, and packaging technologies; and to treat end-stage renal disease or irreversible kidney failure. In addition, this segment manufactures solutions and other products for peritoneal dialysis, a home-based therapy; and distributes products for hemodialysis, which is conducted in a hospital or clinic. Baxter International Inc. serves hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, clinical and medical research laboratories, and patients at home under physician supervision in the United States, Europe, the Asia-Pacific, Latin America, and Canada. The company sells its products through its direct sales force, as well as to and through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. Baxter International Inc. was founded in 1931 and is based in Deerfield, Illinois.
Medicine Infectious Diseases Disorders Dialysis Membrane Technology Hemodialysis Nutrition Products End Stage Renal Disease Burns Hemophilia Kidney Kidney Disease Renal Dialysis Antitrypsin Deficiency Kidney Dialysis Nephrology Alpha 1 Antitrypsin Drug Wholesalers Immune Disorders Kidney Failure Peritoneal Dialysis Biosurgery Products Shock

Is BAX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 95.19
52 Week Low 69.1
Average Volume 3,122,303
200-Day Moving Average 85.35
50-Day Moving Average 86.11
20-Day Moving Average 86.02
10-Day Moving Average 84.75
Average True Range 2.14
ADX 20.29
+DI 20.14
-DI 38.85
Chandelier Exit (Long, 3 ATRs ) 85.03
Chandelier Exit (Short, 3 ATRs ) 85.10
Upper Bollinger Band 92.68
Lower Bollinger Band 79.36
Percent B (%b) 0.1
BandWidth 15.49
MACD Line -1.32
MACD Signal Line -0.34
MACD Histogram -0.9771
Fundamentals Value
Market Cap 43.99 Billion
Num Shares 545 Million
EPS 1.65
Price-to-Earnings (P/E) Ratio 48.93
Price-to-Sales 3.44
Price-to-Book 3.85
PEG Ratio 2.01
Dividend 0.64
Dividend Yield 0.79%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 82.41
Resistance 3 (R3) 82.35 81.73 82.13
Resistance 2 (R2) 81.73 81.30 81.76 82.04
Resistance 1 (R1) 81.23 81.04 81.48 81.29 81.94
Pivot Point 80.61 80.61 80.74 80.64 80.61
Support 1 (S1) 80.11 80.18 80.36 80.17 79.52
Support 2 (S2) 79.49 79.92 79.52 79.42
Support 3 (S3) 78.99 79.49 79.33
Support 4 (S4) 79.05